Gassy acids
The consumption of beer is, for some, one of life?s great pleasures but it can leave behind a bitter aftertaste.
The consumption of beer is, for some, one of life’s great pleasures but it can leave behind a bitter aftertaste.
A team of researchers in Austria and Germany has undertaken a study that has revealed that the bitter acids in hops stimulate gastric acid secretion.1 The team compared the effects of five different beers on mechanisms of gastric acid secretion. Organic acids and bitter compounds were quantified by HPLC–DAD and UPLC–MS–MS and tested in human gastric cancer cells (HGT-1). This was performed using a pH-sensitive fluorescent dye that determines the intracellular pH and would indicate proton secretion. They also measured the expression of four genes, coding the H+/K+-ATPase, ATP4A, the histamine receptor, HRH2, the acetylcholine receptor, CHRM3, and the somatostatin receptor, SSTR2, by quantitative polymerase chain reaction (qPCR).
Ethanol and the organic acids succinic acid, malic acid and citric acid contributed to some extent to the effect of beer. The bitter acids, α-, ß- and iso-α-acids, were identified as potential components promoting gastric acid secretion. They also promoted up-regulation of CHRM3 gene expression by a maximum factor of 2.01 compared with that of untreated control cells with a correlation to their respective bitterness.
The potential is, therefore, present for brewers to produce beers that do not generate gastric acids in a large quantity.
1. Veronika Somoza et al., J. Agric, Food Chem., 60(6), 1405–1412 (2012).
This story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
